AU1925501A - Complexes of alkylphosphonic acids - Google Patents
Complexes of alkylphosphonic acidsInfo
- Publication number
- AU1925501A AU1925501A AU19255/01A AU1925501A AU1925501A AU 1925501 A AU1925501 A AU 1925501A AU 19255/01 A AU19255/01 A AU 19255/01A AU 1925501 A AU1925501 A AU 1925501A AU 1925501 A AU1925501 A AU 1925501A
- Authority
- AU
- Australia
- Prior art keywords
- complexes
- alkylphosphonic acids
- alkylphosphonic
- acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
- A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
- A61K51/1227—Micelles, e.g. phospholipidic or polymeric micelles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Materials Engineering (AREA)
- Radiology & Medical Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16742799P | 1999-11-24 | 1999-11-24 | |
US60167427 | 1999-11-24 | ||
PCT/US2000/032057 WO2001037883A1 (en) | 1999-11-24 | 2000-11-22 | Complexes of alkylphosphonic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1925501A true AU1925501A (en) | 2001-06-04 |
Family
ID=22607340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19255/01A Abandoned AU1925501A (en) | 1999-11-24 | 2000-11-22 | Complexes of alkylphosphonic acids |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1925501A (en) |
WO (1) | WO2001037883A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7381426B2 (en) | 2002-01-24 | 2008-06-03 | Southwest Research Institute | Targeted delivery of bioactive factors to the systemic skeleton |
DE10222481A1 (en) * | 2002-05-22 | 2003-12-04 | Eucro Europe Contract Res Gmbh | Contrast agent for use in imaging |
JP2007502833A (en) * | 2003-08-21 | 2007-02-15 | サウスウエスト・リサーチ・インスティチュート | Nanoparticles targeted to the skeleton |
US7311901B2 (en) * | 2003-10-10 | 2007-12-25 | Samyang Corporation | Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5183815A (en) * | 1991-01-22 | 1993-02-02 | Merck & Co., Inc. | Bone acting agents |
AU705549B2 (en) * | 1995-06-07 | 1999-05-27 | Promega Biosciences, Inc. | Phosphonic acid-based cationic lipids |
-
2000
- 2000-11-22 AU AU19255/01A patent/AU1925501A/en not_active Abandoned
- 2000-11-22 WO PCT/US2000/032057 patent/WO2001037883A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001037883A1 (en) | 2001-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6972398A (en) | Phosphonic acid derivatives | |
AU6482398A (en) | Sulfonylaminocarboxylic acids | |
AU2006699A (en) | Phosphinic alkanoic acid derivatives | |
AU2557500A (en) | Methods of making compounds | |
AU7164198A (en) | Method of preparing salicyloylamino acids | |
AU6045900A (en) | Interaction-activated proteins | |
AU7902400A (en) | Method for the preparation of 5-carboxyphthalide | |
AU5047399A (en) | Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition | |
AU1893901A (en) | Connector | |
AU1559199A (en) | Isothiazolcarboxylic acid derivatives | |
AU2001273761A1 (en) | Preparation of (r)-2-alkyl-3-phenylpropionic acids | |
AU2445601A (en) | Mammalian protein phosphatases | |
AU1268400A (en) | Isothiazolecarboxylic acid derivatives | |
AU4932899A (en) | Processes for the preparation of metallocene complexes | |
AU5382200A (en) | Muc1 ligands | |
AU2982000A (en) | Preparation of 9-hydrocarbyl-9-phosphabicyclononanes | |
AU5536599A (en) | Process for the preparation of neotame | |
AU1303201A (en) | Alkoxyiminoalkanoic acid derivatives | |
AU5504999A (en) | Production of proteins | |
AU3488700A (en) | Luminescent metal-ligand complexes | |
AU3248000A (en) | Manufacture of polyketones | |
AUPP193498A0 (en) | Cemetery walls | |
AU9650398A (en) | Piperazine-cyclodextrin complexes | |
AU1925501A (en) | Complexes of alkylphosphonic acids | |
AU7075498A (en) | Process for the preparation of trifluoroethoxyarenecarboxylic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |